首页> 外文期刊>Clinics in dermatology >Psoriasis in the mature patient: Therapeutic approach in the era of biologics
【24h】

Psoriasis in the mature patient: Therapeutic approach in the era of biologics

机译:成熟患者的牛皮癣:生物学时代的治疗方法

获取原文
获取原文并翻译 | 示例
       

摘要

Management of psoriasis in elderly patients may be challenging due to a small number of studies investigating this specific population. When treating a mature patient, special consideration should be given to multiple comorbidities, progressive functional impairment of several organs, immunosenescence, possible adverse effects, and polypharmacy. Due to the chronic nature of the disease and continuing rise in life expectancy, the prevalence of psoriasis among elderly is also expected to rise. Because many different therapies are available for treatment of psoriasis, we have reviewed those that have been investigated in the aging population. Although biologics have revolutionized the therapy of psoriasis due to targeted mechanism of action, high efficacy and low rate of adverse events, studies on the elderly population with psoriasis are scarce. Further clinical research and development of specific treatment guidelines in geriatric population are needed to optimize the therapeutic approach in this population. (C) 2018 Published by Elsevier Inc.
机译:由于调查这种特定人群的少数研究,老年患者的牛皮癣管理可能是挑战。当治疗成熟患者时,应特别考虑到多种合并症,逐渐函数损害的几种器官,免疫倒血,可能的不良影响和多药物。由于疾病的慢性质和预期寿命继续升高,老年人牛皮癣的患病率也预计会增加。因为许多不同的疗法可用于治疗牛皮癣,所以我们已经审查了在老龄化人口中调查的疗法。尽管生物学革命了由于目标作用机制,高疗效和不良事件的低速率,但对牛皮癣的老年人口的研究是稀缺的。需要进一步的临床研究和发展老年群体的特定治疗准则,以优化本人的治疗方法。 (c)2018年由elsevier公司发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号